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StaurosporineThe putative tumor suppressor Mst1, when cleaved to its 36 kDa cleaved form, ampliﬁes apoptotic
signals. We found that Mst1 was predominantly expressed in its full-length form in 76% (17/25
cases) of hepatocellular carcinoma (HCC) tumors. Mst1 cleavage was basically absent in HCC cells.
Ectopic full-length Mst1 expression increased the growth of HCC cells by 55–80% within 3 days after
transfection. Expression of exogenous NORE1B, a tumor suppressor commonly lost in HCC tumors
(56% of our cohort), was sufﬁcient to suppress the growth promotion of full-length Mst1. Hence,
Mst1 exhibits a growth promoting activity in HCC cells upon NORE1B downregulation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Recent studies on multiple solid cancers indicate that the Mam-
malian Sterile 20-like Kinase 1 (Mst1/Stk4) is a putative tumor
suppressor [1,2]. Conditional Mst1 ablation studies in mice have al-
ready demonstrated the tumor suppressor role of Mst1 against
spontaneous liver cancer development [3,4]. Mst1 was originally
identiﬁed as a proapoptotic cytoplasmic kinase important for
amplifying the apoptotic signals when cleaved to its 36 kDa
cleaved form by caspases [5]. A recent study by Zhou et al. showed
that the full-length Mst1 is the predominant form expressed in
HCC patient tumors, while the pro-apoptotic cleaved form is fre-quently absent [3]. At present, the functional role of this widely ex-
pressed full-length Mst1 has not been studied yet and the biologic
implication of full-length Mst1 in HCC tumorigenesis remains
undeﬁned.
Phosphorylation of Mst1 by Akt has been implicated in limiting
the pro-apoptotic activity of Mst1 in human ovarian and prostate
cancer cells [6,7]. In addition, the pro-apoptotic activity of Mst1
is also regulated by the RAS Association Family members, RASSF1
and NORE1 (RASSF5) [8]. Due to the frequent absence of RASS-
F1A/NORE1B expression in HCC tumors [9], it is highly possible
that the normal biological functions of Mst1 may have been altered
in HCC tumor cells.
In this study, we have reported for the ﬁrst time that the full-
length Mst1 harbors a growth promoting activity in human HCC
models. We found that ectopic expression of full-length Mst1 did
not induce apoptosis in multiple HCC cell lines. Surprisingly, the
full-length Mst1 enhanced the growth of HCC cells particularly in
high cell density. Furthermore, we also demonstrated that the ab-
sence of NORE1B expression in HCC provided a permissive envi-
ronment for the full-length Mst1 to promote HCC cellular growth.
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2.1. Patients samples
The patient tissue collection and research study protocol was
approved by the Joint Chinese University of Hong Kong and Hospi-
tal Authority New Territories East Cluster (CUHK-NTEC) Clinical
Research Ethics Committee. Twenty-ﬁve tumor and adjacent nor-
mal liver tissue pairs were randomly selected from our primary
HCC tissue collections. Clinical characteristics of the selected sam-
ples are listed in Supplementary Table 1.
2.2. Chemicals and plasmids
Mst1 and its kinase dead mutant (Mst1KD) expression plasmids
were obtained from Addgene (Cambridge, MA, USA) and NORE1B
mammalian expression plasmid was from Origene (Rockville, MD,
USA). Mst1 full-length cDNA was subcloned with the hemaglutinin
(HA) tag into pcDNA3.1 (Invitrogen, Carslbad, CA, USA). Myc-tagged
Mst1 mammalian expression plasmid was a gift from Dr. Yukiko
Gotoh (Universityof Tokyo, Tokyo, Japan). Cell culture reagentswere
obtained from Invitrogen (Carslbad, CA, USA). General chemicals
were obtained from Sigma–Aldrich (St. Louis, MO, USA).
2.3. Mst1 mRNA expression meta-analysis
Cancer microarray meta-analysis was performed on multiple
HCC RNA expression datasets using the Nextbio Public software
(https://www.nextbio.com/b/nextbio.nb).
2.4. Cell culture and transfection
HEK293T cells (ATCC, Manassas, VA, USA), HCC cell lines (Hep3B
(ATCC, Manassas, VA, USA), PLC/PRF/5(ATCC, Manassas, VA, USA),
Huh-7 (JCRB Cell Bank, Japan)), and immortalized normal human
hepatocytes MIHA (Brown et al., 2000) [10] were cultured in
DMEM + 10% FBS with penicillin and streptomycin. The gastric
cancer cell line AGS (ATCC, Manassas, VA, USA) was cultured in
RPMI1640 + 10% FBS with penicillin and streptomycin. Transfec-
tion was done with Lipofectamine 2000 (Invitrogen, Carslbad, CA,
USA) according to the manufacturer’s instructions. For stable clone
selection, the transfected cells were selected and maintained with
700 lg/ml G418.
2.5. Western blotting
Aliquots of cell/tissue lysates containing 50 lg protein were re-
solved on 10% SDS–PAGE and transferred to nitrocellulose mem-
branes. Detailed procedures can be found in the Supplementary
Methods.Table 1
Upregulation of Mst1 RNA in cirrhotic livers and HCC livers revealed by RNA expression a
RNA expression dataset GEO ser
Accessi
HCC from HBV+ patient vs. adjacent non-tumor tissue GSE350
Liver from patients with HCV cirrhosis vs. normal liver GSE143
Liver from patients with HCV HCC and cirrhosis vs. normal liver GSE143
Cirrhotic liver without HCC vs. normal liver GSE676
Low-grade dysplastic liver tissue vs. normal liver GSE676
Liver from very early HCC patients vs. normal liver GSE676
Liver from early HCC patients vs. normal liver GSE676
Liver from advanced HCC patients vs. normal liver GSE676
Liver from very advanced HCC patients vs. normal liver GSE6762.6. Cell viability assays
Detailed procedures have been described in the Supplementary
Methods.
2.7. Statistical analysis
Data were expressed as mean ± S.E.M. Statistical analyses were
performed with GraphPad Prism version 4.03 for Windows (Graph-
Pad Software, San Diego California USA). Statistical signiﬁcance in
each experiment was determined by unpaired t test for two group
comparison, or one-way ANOVA followed by Dunnett’s test/Bon-
ferroni’s test for multiple group comparison, with a 95% conﬁdence
level (i.e., P < 0.05).
Other methods are described in the Supplementary Method.
3. Results
3.1. Mst1 mRNA is upregulated in HCC tumors and cell lines
To investigate the role of Mst1 in HCC, we ﬁrst examined Mst1
mRNA expression by meta-analysis of published RNA expression
microarray data from three published studies on HCC: (1) Chen
et al. (2002) (76 adjacent normal liver tissues and 104 HCC liver
tissues; disease samples were HBV and/or HCV associated samples)
[11], (2) Wurmbach et al. (2007) (10 normal, 35 HCC, and 13 cir-
rhotic livers; disease samples were HCV-associated) [12], and (3)
Mas et al. (2008) (19 normal livers, 38 HCC livers, and 58 cirrhotic
livers; disease samples were HCV-associated) [13] (Table 1). Our
analysis showed that Mst1 was upregulated in HCC and in cirrhotic
livers by 1.3 to 1.75-fold. RT-PCR showed that increased Mst1
mRNA was increased on average by 1.59 ± 0.52 folds in 15/16 tu-
mor samples (except for Patient 6) from our patient tumor cohort
(Supplementary Fig. 1). Upregulation of Mst1 mRNA expression
was also detected in 3 HCC cell lines with various p53 and HBV
genomic integration statuses [14]: Hep3B (HBV genome inte-
grated, p53-null), PLC/PRF/5 (HBV genome integrated, p53 mu-
tated), Huh7 (HBV negative, p53 mutated) when compared with
normal liver tissues (Supplementary Fig. 2).
3.2. Full-length Mst1 is the predominant form in HCC patient tumors
Next, we examined the expression of Mst1 protein in human
HCC tumors by Western blotting using an antibody which can de-
tect both the full length (FL) and the proapoptotic 36 kDa cleaved
form (NT) [3] (Validation was done with HEK293T ﬁbroblasts
(293T) overexpressing Mst1 as shown in Supplementary Fig. 3).
Full-length Mst1 protein was overexpressed in 60% of the HCC pa-
tient tumor tissues (15 out of 25 samples) (Fig. 1). Similar to the
previous ﬁndings of Zhou et al. (2009), 17 sample pairs (76% ofrray meta-analysis.
ies Mst1 References
on No. Fold change P value
0 1.37 0.0122 [11]
23 1.66 1.4 x 1015 [13]
23 1.75 3.8 x 107 [13]
4 1.43 0.002 [12]
4 1.28 0.0217 [12]
4 1.4 0.002 [12]
4 1.56 0.0043 [12]
4 1.58 0.0005 [12]
4 1.54 0.0092 [12]
Fig. 1. Mst1 is expressed predominantly as the full length form in HCC tumor tissues. The Mst1 cleaved form was found in the adjacent normal tissues (N), but not commonly
found in the HCC tumors (T). The expression levels of Akt and phosphor-Akt(Ser473) were also shown. Endogenous actin levels were shown as the loading controls between
samples. FL: full-lenth form; NT: cleaved form.
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Among these pairs, 6 of them had no detectable Mst1 cleavage in
their adjacent normal tissues, while 11 pairs showed Mst1 cleav-
age only in the adjacent normal tissues. The NT form was only seen
in six tumor samples (24% of the tumors; Patients 6, 7, 8, 11, 22,
and 26). Several tumor samples (Patients 2, 8, 9, 16, 17, 20, 23,
and 24) showed an intermediate species above 36 kDa, which
could be a partially cleaved product of Mst1. To determine any
Mst1 gene mutation affecting the caspase-mediated cleavage, we
selected six sample pairs (Patients 1, 2, 4, 5, 9, and 11) for sequenc-
ing analysis. No mutation in the caspase recognition sites (Asp326,
Asp349) prior to the cleavage sites were found in the Mst1 mRNA
sequence of all of the samples (Supplementary Table 3).
Previous studies showed that Akt prevents the cleavage of Mst1
upon apoptotic stimulation by phosphorylation of Mst1 at Thr120
and Thr387 [7,15]. In our patient samples, no correlation between
Akt activation (pAkt-Ser 473) with the Mst1 cleavage could be
found (Fig. 1). Indeed, in 40% of the patient samples (10 out of
25), Mst1 cleavage was still observed in the adjacent normal tis-
sues even in the presence of high pAkt levels. We could not detect
the phosphorylation of Mst1 at Thr120 or Thr387 due to the
unavailability of those speciﬁc antibodies.3.3. Overexpression of Mst1 did not induce apoptosis, but rather
increased HCC cell viability
In HCC cell lines Hep3B, PLC/PRF/5, and Huh-7, Mst1 was ex-
pressed mainly as full-length proteins (FL) (Fig. 2A). The NT form
of Mst1 was only found in the normal liver tissues and non-tumor-
igenic immortalized normal hepatocytes MIHA [10]. We could not
detect the protein expression of Mst2 in the HCC cell lines by Wes-
tern blotting (Supplementary Fig. 5). The pAkt(Ser473) levels were
higher in Hep3B and PLC/PRF/5 when compared with Huh-7 and
MIHA. However, no correlation between Akt activation status and
Mst1 cleavage was found in the HCC cell lines.
Previous studies on multiple mammalian cell lines showed that
overexpression of Mst1 induces Mst1 cleavage [5,16]. We were
able to recapitulate this in the human embryonic kidney HEK293T
and the gastric cancer cell line, AGS (Fig. 2B). However, in Hep3B,
PLC/PRF/5, and Huh-7, ectopic expression of Mst1 did not induce
the presence of the NT form (Fig. 2B). Ectopic expression of Mst1
did not increase basal level of caspase activity (as reﬂected by
the cleavage of the endogenous caspase substrate PARP) (Fig. 2C),
but rather tended to reduce the basal apoptosis level as revealed
by Nucleosome ELISA (Fig. 2D).
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Fig. 2. Proteolytic cleavage of Mst1 is absent in HCC cells. (A) Mst1 was expressed as the full length (FL) proteins, but not in the 36 kDa NT form in HCC cells. Both forms were
expressed in normal human livers and the immortalized hepatocyte MIHA. The levels of pAkt (Ser473), Akt, and NORE1B were also shown. Quantitation of the endogenous
NORE1B levels was indicated underneath the blots. (B) EctopicMst1 expression did not induceMst1 cleavage ofMst1 in HCC cells. On the other hand, Mst1 cleavagewas seen in
HEK293Tcells and the gastric cancer cell AGSuponMst1overexpression. (C) Apoptosis signaling, indicatedby thePARP cleavage,wasnot changedupon theMst1overexpression,
n = 3 experiments. (D)NucleosomeELISA indicated that basal apoptosis levelswere not enhanced, butwith a tendency of reduction,whenoverexpressingMst1 inHCCcells,n = 4
experiments. (E) Overnight treatment of Hep3B with increasing concentrations of apoptosis stimuli 0.125 lM staurosporine induced cell death in a dose-dependent manner.
However, staurosporine could not induce Mst1 cleavage, but elevated the pAkt(Ser473 levels). (F) Combined overnight treatment of pAkt(Ser473) by PI3 kinase inhibitor
LY294002 and staurosporine effectively induced caspase activation (indicated by the elevated cleaved PARP level), but was still unable to induce massive Mst1 cleavage.
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500 Y.-K. Ng et al. / FEBS Letters 587 (2013) 496–503Other previous studies in BJAB and HeLa cells showed that the
DNA damaging agent staurosporine can induce caspases-mediated
cleavage of Mst1 [5]. Overnight treatments of Hep3B with
0.125 lM staurosporine induced cell death in 30% of the cell pop-
ulation, but failed to induce the Mst1 cleavage (Fig. 2E). The p-Akt
(Ser473) levels were often elevated during the staurosporine treat-
ment. To lower the endogenous Akt activation, we thus pretreated
Hep3B cells with 50 lM PI3 kinase inhibitor LY294002 for 2 h.
However, overnight combined treatment of staurosporine
(0.125 lM) and LY294002 (50 lM) still could not induce massive
Mst1 cleavage in the presence of low Akt activation (Fig. 2F). Under
these conditions, caspase activity was highly induced as indicated
by the PARP cleavage. Similar observations were also found in
Huh7 cells (data not shown). Hence, Akt might not play a major
role in regulating the Mst1 cleavage in HCC cells.Fig. 3. Overexpression of Mst1 increased the HCC cell growth. (A) Transfection of Mst1
(white bars) in HCC cells, but not in MIHA and the gastric cancer AGS cells. The viable c
kinase dead Mst1 (Mst1KD) did not increase HCC cell growth (grey bars). (B) Western bl
full-lenth form; NT: cleaved form. (C) Hep3B stable clones overexpressing Mst1 full-leng
of viable cell count increases between Mst1 overexpressing stable cells (black bars) and
⁄P < 0.05, ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001, n = 3–4 experiments in triplicates.Surprisingly, transfection of the full-length Mst1 signiﬁcantly
increased the growth of all 3 HCC cell lines by 55–80% (Figs. 3A
and 3B). No signiﬁcant change in the viable cell count was ob-
served in the transfection of immortalized normal hepatocytes
MIHA cells with Mst1, or HCC cells with Mst1KD. This indicated
that the growth promoting activity of Mst1 was HCC-speciﬁc and
dependent on the kinase activity of Mst1. As shown in Fig. 3A, tran-
sient transfection of full-length human Mst1 in HEK293T cells did
result in growth inhibition (27.68 ± 3.66% decrease) within 3 days
after transfection. Immunocytochemical staining showed that the
full-length Mst1 and Mst1KD (Mst kinase dead mutant) proteins
showed mainly cytoplasmic localization (Supplementary Fig. 6).
No induction of chromatin condensation was seen in Mst1 and
Mst1KD overexpressing cells. To investigate the effects of pro-
longed Mst1 overexpression on HCC cell growth, we generated a(black bars) increased total viable cell count cells compared with the control vector
ell count of 293T cells was signiﬁcantly reduced by Mst1 transient expression. The
ot examples showed the Mst1/Mst1KD levels after transfection in each cell line. FL:
th had increased cellular growth compared with the control vector. (D) Quantitation
the control cells (white bars) at different initial cell densities. ns: not signiﬁcant,
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ing stable cells had a faster growth rate after cultured for ten days
compared with the stable lines carrying the control vector (Control
Stable Cells) (Fig. 3C). The delayed difference in growth rate be-
tween the Mst1 overexpressing cells and the control cells sug-
gested that the growth enhancement effects of Mst1 was cell-
density dependent. Thus, we plated the control cells and the
Mst1 overexpressing cells at two initial densities (8  104 and
2  105 cells per well) and measured the total number of viable
cells after 3 days. We found that the increase in viable cell count
(43.29 ± 6.14% increase, P < 0.001) was more prominent in the
Mst1 overexpressing cells plated at the higher density: 2  105
cells per well (Fig. 3D and Supplementary Fig. 7).
3.4. Expression of exogenous NORE1B limits the growth promoting
effects of Mst1 in HCC cells
It has been reported that NORE1B gene is downregulated by epi-
genetic silencing in the majority of HCC tumors [9]. We found that
NORE1B expression was downregulated in the 14 tumor tissues
among 25 patient pairs (56%) (Fig. 4A). The other 11 tumor tissues
showed elevated or unchanged NORE1B expression levels (44%).
Twenty-four of the adjacent normal liver tissues all showed NOR-
E1B expression while 1 adjacent normal tissue failed to show NOR-
E1B expression). However, no correlation between NORE1B
downregulation and the absence of Mst1 cleavage was identiﬁed
in the patient tumor samples (Figs. 1, 4A and Supplementary
Fig. 8). We also observed downregulation of NORE1B expression
in our HCC cell models (Fig. 4B). Given the reported regulatory role
of NORE1 on Mst1 activity [8], we hypothesized that downregula-0
20
40
60
80
100
120
140
Vector Con
NORE1B
**
Control
Stable Cells
Vi
ab
le
 c
el
l c
ou
nt
(%
 c
on
tr
ol
)
A
B
ns
Actin
NORE1B
N   T   N   T    N    T     N    T     N   T    N    T
N    T    N   T     N   T     N    T     N    T    N   
NORE1B
Actin
Patient         1        2          3            4            5 6      
Patient           14       15         16          17         18 19
Fig. 4. Downregulation of NORE1B contributes to the altered biological actions of Mst1
tumor samples. (B) Transfection of the expression vectors of NORE1B (black bars) signiﬁ
Mst1. White bars: transfection with control vector. ns: not signiﬁcant, ⁄⁄⁄P < 0.001, n = 4tion of NORE1B might provide a permissive environment for the
manifestation of the unexpected growth promoting activity of
full-length Mst1 in HCC cells. Consistent with this, ectopic expres-
sion of NORE1B in the Mst1 stable cell line signiﬁcantly suppressed
(P < 0.0001) the growth promoting effect of Mst1 to a level com-
pared with the vector control (Fig. 2A). However, this suppressive
effect of NORE1B was subtle (P = 0.3903) in the control stable
clones, indicating that the suppressive effect of NORE1B was spe-
ciﬁc to the stable cells overexpressing full-length Mst1 proteins.
Thus, these results suggest that NORE1B downregulation in HCC
was highly related to the observed growth promoting function of
full-length Mst1.
4. Discussion
We found that full-length Mst1 is consistently present in HCC
tumors along with the frequent absence of the 36 kDa cleaved form
as shown in previous reports [3]. Our results indicated that the ab-
sence of Mst1 cleavage in HCC was unrelated to any somatic muta-
tion of the Mst1 gene. We found that full-length Mst1 retained a
growth promoting activity that was more prominent when HCC
cells were grown in high density. At the ﬁrst glance, our ﬁndings
seem contradictory with the putative tumor suppressive role of
Mst1 in several studies on human cancers [1–3,17]. The Sterile
20-like Kinases (Stks) family, in which Mst1 belongs to, often has
a dual mode of contradictory actions. For example, PAK2 (p21 Acti-
vated Kinase 2) has a dual regulatory function for both cell survival
and apoptosis [18, 19]. Hence, it is not surprising that Mst1 also
possess a dual mode of contradictory actions in cellular survival
regulation.trol
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Fig. 5. Diagram representing the dysregulation of Mst1 functions in HCC. Frequent downregulation of NORE1B in HCC provides a permissive cellular environment for the full-
length Mst1 to exert its growth promoting activity. In normal hepatocyte, the presence of NORE1B ensures that the Mst1 behaves as a proapoptotic factor.
502 Y.-K. Ng et al. / FEBS Letters 587 (2013) 496–503Furthermore, recent ﬁndings have shown that the presence of
endogenousMst1 does not always prevent the development of liver
cancers. For example, ablation of the Mst1 interacting partners
NORE1 in mice, which causes high expression levels of endogenous
Mst1, still favors tumor development or K-RasG12V induced trans-
formation in livers [20]. In this present study, for the ﬁrst time, we
have demonstrated that the growth enhancement effect induced
by ectopic Mst1 expression was related to the downregulation of
NORE1B in HCC cells. We found that the expression of NORE1B
was frequently absent in multiple HCC cells and tumor tissues. We
also discovered that the enhanced growth of the full-length Mst1
overexpressing Hep3B cells was attenuated when exogenous NOR-
E1B proteins were coexpressed. However, the transfection of NOR-
E1B just subtly affected the growth of the control stable cells. This
strongly indicated the dependency of the cellular Mst1 protein con-
tent for NORE1B to exert its inhibitory effects on HCC cell growth.
Hence, our ﬁndings suggest that downregulation of NORE1B expres-
sion compromises the safeguard for inappropriate Mst1 activation
in HCC, resulting in Mst1 mediated growth promotion (Fig. 5).
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